Role of glomerular filtration rate in controlling blood pressure early in diabetes.
作者信息
Brands Michael W, Labazi Hicham
机构信息
Department of Physiology, CA-3098, Medical College of Georgia, Augusta, GA 30912-3000, USA.
出版信息
Hypertension. 2008 Aug;52(2):188-94. doi: 10.1161/HYPERTENSIONAHA.107.090647. Epub 2008 Jul 7.
Abstract
摘要
相似文献
1
Role of glomerular filtration rate in controlling blood pressure early in diabetes.
Hypertension. 2008 Aug;52(2):188-94. doi: 10.1161/HYPERTENSIONAHA.107.090647. Epub 2008 Jul 7.
2
SGLT2 Inhibitors and the Diabetic Kidney.
Diabetes Care. 2016 Aug;39 Suppl 2:S165-71. doi: 10.2337/dcS15-3006.
3
Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate.
Diabetologia. 2004 Nov;47(11):1936-9. doi: 10.1007/s00125-004-1542-0. Epub 2004 Nov 17.
4
Diet therapy in diabetic nephropathy.
Contrib Nephrol. 2007;155:50-58. doi: 10.1159/000100996.
5
Cholesterol as a predictor of progression in diabetic renal disease.
Contrib Nephrol. 1997;120:39-47. doi: 10.1159/000059822.
6
Current concepts of renal hemodynamics in diabetes.
J Diabetes Complications. 1995 Oct-Dec;9(4):304-7. doi: 10.1016/1056-8727(95)80028-d.
7
Natural history and pathogenesis of diabetic nephropathy.
J Diabet Complications. 1991 Apr-Sep;5(2-3):72-5. doi: 10.1016/0891-6632(91)90022-h.
8
Preventing kidney failure in people with diabetes.
Diabet Med. 2014 Nov;31(11):1280-3. doi: 10.1111/dme.12535.
9
Microalbuminuria in insulin-dependent diabetes--strategies to prevent diabetic nephropathy.
Nephron. 1993;65(4):511-21. doi: 10.1159/000187556.
10
Progressive Decline in Estimated Glomerular Filtration Rate in Patients With Diabetes After Moderate Loss in Kidney Function-Even Without Albuminuria.
Diabetes Care. 2019 Oct;42(10):1886-1894. doi: 10.2337/dc19-0349. Epub 2019 Jun 20.
引用本文的文献
1
Sex Differences in Association of Elevated Blood Pressure with Variables Characterizing Cardiometabolic Risk in Young Subjects with or Without Metabolic Abnormalities.
Int J Environ Res Public Health. 2020 May 21;17(10):3612. doi: 10.3390/ijerph17103612.
2
Mechanisms of Synergistic Interactions of Diabetes and Hypertension in Chronic Kidney Disease: Role of Mitochondrial Dysfunction and ER Stress.
Curr Hypertens Rep. 2020 Feb 3;22(2):15. doi: 10.1007/s11906-020-1016-x.
3
Amlodipine Reduces Inflammation despite Promoting Albuminuria in the Streptozotocin-Induced Diabetic Rat.
Nephron Extra. 2012 Jan;2(1):205-18. doi: 10.1159/000339436. Epub 2012 Jul 6.
4
Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management.
Adv Chronic Kidney Dis. 2011 Jan;18(1):28-41. doi: 10.1053/j.ackd.2010.10.003.
5
Continuously measured renal blood flow does not increase in diabetes if nitric oxide synthesis is blocked.
Am J Physiol Renal Physiol. 2008 Nov;295(5):F1449-56. doi: 10.1152/ajprenal.00004.2008. Epub 2008 Aug 27.
本文引用的文献
1
The collecting duct is the major source of prorenin in diabetes.
Hypertension. 2008 Jun;51(6):1597-604. doi: 10.1161/HYPERTENSIONAHA.107.107268. Epub 2008 Apr 14.
2
Lack of A1 adenosine receptors augments diabetic hyperfiltration and glomerular injury.
J Am Soc Nephrol. 2008 Apr;19(4):722-30. doi: 10.1681/ASN.2007060721. Epub 2008 Feb 6.
3
Prehypertension: demographics, pathophysiology, and treatment.
Curr Hypertens Rep. 2007 Aug;9(4):264-8. doi: 10.1007/s11906-007-0049-8.
4
Obesity and insulin resistance as risk factors for chronic kidney disease.
J Cardiometab Syndr. 2006 Summer;1(3):209-14; quiz 215-6. doi: 10.1111/j.1559-4564.2006.05631.x.
5
Lack of blood pressure salt-sensitivity supports a preglomerular site of action of nitric oxide in Type I diabetic rats.
Clin Exp Pharmacol Physiol. 2007 May-Jun;34(5-6):475-9. doi: 10.1111/j.1440-1681.2007.04597.x.
6
Insulin resistance, metabolic syndrome and endothelial dysfunction.
J Nephrol. 2007 Jan-Feb;20(1):10-4.
7
Blood pressure early in diabetes depends on a balance between glomerular filtration rate and the renin-angiotensin system.
Am J Hypertens. 2006 Dec;19(12):1249-55. doi: 10.1016/j.amjhyper.2006.05.012.
8
The etiology of hypertension in the metabolic syndrome part three: the regulation and dysregulation of blood pressure.
Curr Vasc Pharmacol. 2006 Oct;4(4):321-48. doi: 10.2174/157016106778521643.
9
Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence.
Adv Chronic Kidney Dis. 2006 Oct;13(4):365-73. doi: 10.1053/j.ackd.2006.07.011.
10
Angiotensin receptor blockers: Cardiovascular protection in the metabolic syndrome.
J Renin Angiotensin Aldosterone Syst. 2006 Jun;7 Suppl 1:S12-8. doi: 10.3317/jraas.2006.018.
Zotero 插件